Next Article in Journal
A Systematic Review of Breast Implant-Associated Squamous Cell Carcinoma
Next Article in Special Issue
PD-1/PD-L1 Inhibitors Response in Triple-Negative Breast Cancer: Can Long Noncoding RNAs Be Associated?
Previous Article in Journal
Tolerance and Oncological Outcomes of In-Field Reirradiation for Locally Recurrent Breast Cancer: A Long-Term Single-Center Experience
Previous Article in Special Issue
Regulation of IGF1R by MicroRNA-15b Contributes to the Anticancer Effects of Calorie Restriction in a Murine C3-TAg Model of Triple-Negative Breast Cancer
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Storme, G.A. Breast Cancer: Impact of New Treatments? Cancers 2023, 15, 2205

Department Radiation Oncology, UZ Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium
Cancers 2023, 15(18), 4514; https://doi.org/10.3390/cancers15184514
Submission received: 9 August 2023 / Accepted: 24 August 2023 / Published: 12 September 2023
(This article belongs to the Special Issue Precision Medicine in Breast Cancer Treatment)
There was a cited reference error in the original article [1]. A correction has been made to Section 2, Paragraph 2, Lines 5–14: “Overweight and obese patients were diagnosed later (age at diagnosis: 51.7 ± 12.0 years) than normo-ponderal ones [9]. Breast-adipose-tissue-derived mesenchymal stromal/stem cells (bASCs) were recently identified as crucial components of the tumor microenvironment (TME). Breast-cancer-associated bASCs foster malignancy of breast cancer cells by induction of epithelial–mesenchymal transition and by activation of stemness-associated genes. Mechanistic insight showed how obesity affects the phenotype of bASCs in the TME, and highlights the molecular changes inside breast cancer cells upon interaction with cancer-educated bASCs [10]. Adipose tissue of obese individuals produces inflammatory cytokines and other mediators, creating an environment that promotes cancer invasion and metastasis [11,12]”. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original article has been updated.

Reference

  1. Storme, G.A. Breast Cancer: Impact of New Treatments? Cancers 2023, 15, 2205. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Storme, G.A. Correction: Storme, G.A. Breast Cancer: Impact of New Treatments? Cancers 2023, 15, 2205. Cancers 2023, 15, 4514. https://doi.org/10.3390/cancers15184514

AMA Style

Storme GA. Correction: Storme, G.A. Breast Cancer: Impact of New Treatments? Cancers 2023, 15, 2205. Cancers. 2023; 15(18):4514. https://doi.org/10.3390/cancers15184514

Chicago/Turabian Style

Storme, Guy A. 2023. "Correction: Storme, G.A. Breast Cancer: Impact of New Treatments? Cancers 2023, 15, 2205" Cancers 15, no. 18: 4514. https://doi.org/10.3390/cancers15184514

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop